1-(2-methylpropyl)-7,8-dihydro-6H-quinoline-2,5-dione | 169777-14-4

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: 1-(2-methylpropyl)-7,8-dihydro-6H-quinoline-2,5-dione
• CAS: 169777-14-4
• 化学式: C₁₃H₁₇NO₂
• 分子量: 219.283
• InChiKey: LVLNABQWVRXLIR-UHFFFAOYSA-N

物化性质

• 沸点：
  391.7±31.0 °C(Predicted)
• 密度：
  1.13±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.5
• 重原子数：
  16
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.54
• 拓扑面积：
  37.4
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  1-(2-methylpropyl)-7,8-dihydro-6H-quinoline-2,5-dione 在 titanium(IV) isopropylate 、 sodium tetrahydroborate 作用下， 以 乙醇 、 乙腈 为溶剂， 反应 23.0h， 生成 5-[2-(3,4-Dichloro-phenyl)-ethylamino]-1-isobutyl-5,6,7,8-tetrahydro-1H-quinolin-2-one
  参考文献：
  名称：

  Synthesis and Evaluation of 5-Amino-5,6,7,8-tetrahydroquinolinones as Potential Agents for the Treatment of Alzheimer's Disease

  摘要：

  A series of 5-amino-5,6,7,8-tetrahydroquinolinones was designed and synthesized as acetylcholinesterase inhibitors. The compounds are related to hyperzine A, a naturally occurring cholinesterase inhibitor. They inhibit acetylcholinesterase in vitro, and many are active in vivo in reversing a scopolamine-induced impairment of 24 h memory in a passive avoidance paradigm. Although these compounds were designed as partial structures of huperzine A, it is unlikely that they bind to the enzyme in a similar fashion, since they lack the unsaturated three-carbon bridge of huperzine A and both the quinolinone nitrogen and the amino group must be substituted in order to obtain good enzyme affinity.

  DOI：

  10.1021/jm00018a025
• 作为产物：
  描述：

  7,8-二氢-1H,6H-喹啉-2,5-二酮 、 alkaline earth salt of/the/ methylsulfuric acid 在 lithium hydride 作用下， 生成 1-(2-methylpropyl)-7,8-dihydro-6H-quinoline-2,5-dione
  参考文献：
  名称：

  Synthesis and Evaluation of 5-Amino-5,6,7,8-tetrahydroquinolinones as Potential Agents for the Treatment of Alzheimer's Disease

  摘要：

  A series of 5-amino-5,6,7,8-tetrahydroquinolinones was designed and synthesized as acetylcholinesterase inhibitors. The compounds are related to hyperzine A, a naturally occurring cholinesterase inhibitor. They inhibit acetylcholinesterase in vitro, and many are active in vivo in reversing a scopolamine-induced impairment of 24 h memory in a passive avoidance paradigm. Although these compounds were designed as partial structures of huperzine A, it is unlikely that they bind to the enzyme in a similar fashion, since they lack the unsaturated three-carbon bridge of huperzine A and both the quinolinone nitrogen and the amino group must be substituted in order to obtain good enzyme affinity.

  DOI：

  10.1021/jm00018a025

文献信息

• Verwendung von Chinolin-2,5-dionen in einem Arzneimittel mit einer analgetischen, antipyretischen und/oder einer antiphlogistischen Wirkung
  申请人：Dr. Karl Thomae GmbH

  公开号：EP0338228A2

  公开（公告）日：1989-10-25

  Die vorliegende Erfindung betrifft Arzneimittel, enthaltend Chinolin-2,5-dione der Formel in der A, B, R₁ bis R₃ und X wie in den Ansprüchen 1 bis 6 definiert sind, sowie neue Chinolin-2,5-dione gemäß den An­sprüchen 10 bis 14, welche wertvolle pharmakologische Eigen­schaften aufweisen, insbesondere eine analgetische, antipyre­tische und/oder antiphlogistische Wirkung, neue Zwischenpro­dukte und Verfahren zu ihrer Herstellung.

  本发明涉及含有 2,5-喹啉二酮的药物，其式为 其中 A、B、R₁至 R₃和 X 如权利要求 1 至 6 所定义，以及根据权利要求 10 至 14 所述的新型喹啉-2,5-二酮，它们具有重要的药理特性，特别是镇痛、解热和/或抗血栓作用，以及制备它们的新型中间体和工艺。
• US5068334A
  申请人：——

  公开号：US5068334A

  公开（公告）日：1991-11-26
• Synthesis and Evaluation of 5-Amino-5,6,7,8-tetrahydroquinolinones as Potential Agents for the Treatment of Alzheimer's Disease
  作者：David M. Fink、Gina M. Bores、Richard C. Effland、Francis P. Huger、Barbara E. Kurys、Douglas K. Rush、David E. Selk

  DOI：10.1021/jm00018a025

  日期：1995.9

  A series of 5-amino-5,6,7,8-tetrahydroquinolinones was designed and synthesized as acetylcholinesterase inhibitors. The compounds are related to hyperzine A, a naturally occurring cholinesterase inhibitor. They inhibit acetylcholinesterase in vitro, and many are active in vivo in reversing a scopolamine-induced impairment of 24 h memory in a passive avoidance paradigm. Although these compounds were designed as partial structures of huperzine A, it is unlikely that they bind to the enzyme in a similar fashion, since they lack the unsaturated three-carbon bridge of huperzine A and both the quinolinone nitrogen and the amino group must be substituted in order to obtain good enzyme affinity.